Search Details

Word: novuspharma (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...biotech industry, which is viewed even more nervously by investors, is already being cherry-picked by more confident and cash-rich U.S. companies. In May, Chiron bought out the U.K. vaccine company PowderJect for $886 million. And in June, Seattle-based Cell Therapeutics announced a deal to take over Novuspharma of Milan - Italy's last publicly-traded biotech company - for about $235 million in stock. Even this month's $80 million takeover of U.K. rival Vernalis by British Biotech - a onetime industry star brought low by product failures - only amounts to a merger of lossmakers in a market that right...

Author: /time Magazine | Title: Will This Experiment Work? | 7/13/2003 | See Source »

| 1 |